Lorenz Lehmann

4.5k total citations
75 papers, 2.0k citations indexed

About

Lorenz Lehmann is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Lorenz Lehmann has authored 75 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Cardiology and Cardiovascular Medicine, 29 papers in Molecular Biology and 24 papers in Oncology. Recurrent topics in Lorenz Lehmann's work include Chemotherapy-induced cardiotoxicity and mitigation (20 papers), Peptidase Inhibition and Analysis (13 papers) and Cardiovascular Function and Risk Factors (12 papers). Lorenz Lehmann is often cited by papers focused on Chemotherapy-induced cardiotoxicity and mitigation (20 papers), Peptidase Inhibition and Analysis (13 papers) and Cardiovascular Function and Risk Factors (12 papers). Lorenz Lehmann collaborates with scholars based in Germany, United States and United Kingdom. Lorenz Lehmann's co-authors include Hugo A. Katus, Johannes Backs, Michael M. Kreußer, Markus Heckmann, Daniel Finke, Eric N. Olson, Oliver J. Müller, David M. Patrick, Lars S. Maier and Joseph A. Hill and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Circulation and Journal of Clinical Investigation.

In The Last Decade

Lorenz Lehmann

65 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lorenz Lehmann Germany 23 1.1k 1.0k 458 203 158 75 2.0k
Hind Lal United States 30 1.4k 1.3× 992 1.0× 288 0.6× 307 1.5× 56 0.4× 57 2.4k
Jianjian Shi United States 26 1.4k 1.3× 577 0.6× 349 0.8× 113 0.6× 64 0.4× 38 2.4k
Nour-Eddine Rhaleb United States 32 888 0.8× 1.3k 1.3× 371 0.8× 323 1.6× 84 0.5× 43 2.7k
Xiying Shang United States 19 1.1k 1.0× 612 0.6× 235 0.5× 193 1.0× 44 0.3× 28 1.9k
Anne Pizard France 25 1.2k 1.1× 975 1.0× 111 0.2× 312 1.5× 107 0.7× 39 2.3k
Leonard S. Golfman Canada 18 1.3k 1.3× 808 0.8× 247 0.5× 178 0.9× 138 0.9× 26 2.3k
Ronald Kahn United States 11 969 0.9× 522 0.5× 545 1.2× 263 1.3× 162 1.0× 12 1.8k
Gabriele D’Uva Italy 19 1.0k 1.0× 351 0.3× 355 0.8× 258 1.3× 49 0.3× 31 1.8k
Xifu Liu China 16 698 0.7× 510 0.5× 360 0.8× 177 0.9× 105 0.7× 35 1.2k
Jingyi Gong United States 20 1.0k 1.0× 443 0.4× 451 1.0× 210 1.0× 55 0.3× 35 2.3k

Countries citing papers authored by Lorenz Lehmann

Since Specialization
Citations

This map shows the geographic impact of Lorenz Lehmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lorenz Lehmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lorenz Lehmann more than expected).

Fields of papers citing papers by Lorenz Lehmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lorenz Lehmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lorenz Lehmann. The network helps show where Lorenz Lehmann may publish in the future.

Co-authorship network of co-authors of Lorenz Lehmann

This figure shows the co-authorship network connecting the top 25 collaborators of Lorenz Lehmann. A scholar is included among the top collaborators of Lorenz Lehmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lorenz Lehmann. Lorenz Lehmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Koeckerling, David, Rohin K. Reddy, Joseph Barker, et al.. (2024). Cardiovascular Events After Chimeric Antigen Receptor T-Cell Therapy for Advanced Hematologic Malignant Neoplasms. JAMA Network Open. 7(10). e2437222–e2437222. 9 indexed citations
3.
Bräuer, Jürgen, et al.. (2024). The cardio-oncologic burden of breast cancer: molecular mechanisms and importance of preclinical models. Basic Research in Cardiology. 120(1). 91–112. 3 indexed citations
4.
Finke, Daniel, Hauke Hund, Norbert Frey, Thomas Luft, & Lorenz Lehmann. (2024). EASIX (endothelial activation and stress index) predicts mortality in patients with coronary artery disease. Clinical Research in Cardiology. 114(8). 1008–1018. 12 indexed citations
5.
6.
Korell, Felix, Evangelos Giannitsis, Anita Schmitt, et al.. (2024). Evaluation of all-cause mortality and cardiovascular safety in patients receiving chimeric antigen receptor T cell therapy: a prospective cohort study. EClinicalMedicine. 69. 102504–102504. 14 indexed citations
7.
Chandra, Anchal, et al.. (2022). Cardio-oncology imaging tools at the translational interface. Journal of Molecular and Cellular Cardiology. 168. 24–32. 3 indexed citations
8.
9.
Finke, Daniel, Markus Heckmann, Hauke Hund, et al.. (2021). High-Sensitivity Cardiac Troponin T Determines All-Cause Mortality in Cancer Patients: A Single-Centre Cohort Study. ESC Heart Failure. 8(5). 3709–3719. 20 indexed citations
10.
Finke, Daniel, et al.. (2021). Histone deacetylase 4 deletion broadly affects cardiac epigenetic repression and regulates transcriptional susceptibility via H3K9 methylation. Journal of Molecular and Cellular Cardiology. 162. 119–129. 6 indexed citations
11.
Michel, Lars, Matthias Totzeck, Lorenz Lehmann, & Daniel Finke. (2020). Emerging role of immune checkpoint inhibitors and their relevance for the cardiovascular system. Herz. 45(7). 645–651. 10 indexed citations
12.
Heckmann, Markus, Daniel Finke, Markus S. Anker, et al.. (2019). Evidence for a Cardiac Metabolic Switch in Patients with Hodgkin's Lymphoma. ESC Heart Failure. 6(4). 824–829. 13 indexed citations
13.
Kreußer, Michael M., Lorenz Lehmann, Markus Haass, et al.. (2017). Depletion of cardiac catecholamine stores impairs cardiac norepinephrine re-uptake by downregulation of the norepinephrine transporter. PLoS ONE. 12(3). e0172070–e0172070. 11 indexed citations
14.
Schmitt, Thomas, Regine Mayer‐Steinacker, Frank Mayer, et al.. (2016). Vorinostat in refractory soft tissue sarcomas – Results of a multi-centre phase II trial of the German Soft Tissue Sarcoma and Bone Tumour Working Group (AIO). European Journal of Cancer. 64. 74–82. 32 indexed citations
15.
Bang, Claudia, Charalambos Antoniades, Alexios S. Antonopoulos, et al.. (2015). Intercellular Communication Lessons in Heart Failure. European Journal of Heart Failure. 17(11). 1091–1103. 44 indexed citations
16.
Jarr, Kai-Uwe, Christian Kühn, Lorenz Lehmann, et al.. (2015). Heat-shock-protein 90 protects from downregulation of HIF-1α in calcineurin-induced myocardial hypertrophy. Journal of Molecular and Cellular Cardiology. 85. 117–126. 14 indexed citations
17.
Lehmann, Lorenz, Sebastian J. Buss, Michael M. Kreußer, et al.. (2014). Essential role of sympathetic endothelin A receptors for adverse cardiac remodeling. Proceedings of the National Academy of Sciences. 111(37). 13499–13504. 20 indexed citations
18.
Kreußer, Michael M., Lorenz Lehmann, Stanislav Keranov, et al.. (2014). Cardiac CaM Kinase II Genes δ and γ Contribute to Adverse Remodeling but Redundantly Inhibit Calcineurin-Induced Myocardial Hypertrophy. Circulation. 130(15). 1262–1273. 133 indexed citations
19.
Lehmann, Lorenz, et al.. (2014). The role of endothelin-1 in the sympathetic nervous system in the heart. Life Sciences. 118(2). 165–172. 23 indexed citations
20.
Kristen, Arnt V., Katrin Ackermann, Sebastian J. Buss, et al.. (2013). Inhibition of apoptosis by the intrinsic but not the extrinsic apoptotic pathway in myocardial ischemia-reperfusion. Cardiovascular Pathology. 22(4). 280–286. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hind Lal Breakdown of academic impact, for papers by Jianjian Shi Breakdown of academic impact, for papers by Nour-Eddine Rhaleb Breakdown of academic impact, for papers by Xiying Shang Breakdown of academic impact, for papers by Anne Pizard Breakdown of academic impact, for papers by Leonard S. Golfman Breakdown of academic impact, for papers by Ronald Kahn Breakdown of academic impact, for papers by Gabriele D’Uva Breakdown of academic impact, for papers by Xifu Liu Breakdown of academic impact, for papers by Jingyi Gong
Rankless by CCL
2026